3 Reasons Humana Inc. Stock Could Rise

Humana's focus on Medicare insurance products means that it's well positioned to benefit from retiring baby boomers.

Aug 29, 2014 at 6:30PM

Investors have a lot of choices when it comes to investing in healthcare insurers, but considering the specific markets targeted by each insurer may make it easier to find the right investment. For example, investors interested in insurers benefiting from Medicaid expansion may be more interested in specialty healthcare insurers like Molina Health that get most of their revenue from running state health insurance programs.

Investors looking for diversification may be better served by UnitedHealth Group because its customers include individuals, small and big businesses, and those enrolled in government programs. If, instead, investors are looking to own a Medicare-based insurer that is likely to benefit from aging baby boomers, they may find that they're best served by focusing on Humana (NYSE:HUM), which gets more than 75% of its revenue from Medicare-related products.

Of course, there's no telling whether any of those stocks will go up or down -- Humana included. After all, stocks rise and fall based on any number of factors, and that's particularly true of insurers, given that they're highly exposed to regulatory risk. With that in mind, let's consider three reasons why Humana's shares may go up, rather than down.

Humana Exterior Angle

Source: Humana.

1. Millions of potential new members
Insurance is a business of scale. The more members you have, the more money you can make.

Because the over-65 population is expected to double as 10,000 baby boomers hit that milestone every day between now and 2029, demand for Medicare is likely to surge. That could mean good things for Humana, given that it markets Medicare Advantage plans that can be purchased by boomers as a Medicare alternative.

Just how much potential demand for Medicare products could there be? Consider that, in 2010, 11% of all Americans were age 65 years or older, and by 2030, that percentage will increase to 18%.

That trend is already benefiting Humana. Membership in Humana's individual Medicare Advantage plans grew 16.4%, or 333,300 members, to 2.36 million people in the past year, lifting Humana's revenue from Medicare plans to $8.8 billion in the second quarter from $7.5 billion a year ago.

2. Strength on the edges
During the coming decade, Medicare is going to be the biggest reason for Humana's success or failure; but that doesn't mean that insurance exchange marketplaces won't have an impact on Humana in the short term. Currently, sales from the ACA marketplace represent just 1% of sales, but increasingly more members coming from the exchanges still means revenue growth for the company.

Thanks to the exchanges, Humana's individual membership jumped by 122%, to 1.1 million people during the second quarter. That helped its sales of fully insured products climb from $1.6 billion a year ago to $2.2 billion during the quarter.


Source: Humana.

3. Controlling costs
Providing care to seniors isn't cheap. Older patients require more services, and tend to take far more prescription medications than younger patients. That means that Humana will need to be creative if it hopes to keep its expenses in check.

One way it may be able to reduce its cost of care is by increasing its buying power. Currently, Humana operates its own pharmacy benefit manager, which negotiates prices with drugmakers. While Humana's PBM isn't small -- Humana serves 13.6 million members -- it's not nearly as big as CVS Caremark or Express Scripts. If Humana can partner with a larger PBM, it may be able to negotiate lower prices for medicine.

Humana is also rolling out cost-saving programs that boost preventative care, particularly in high-risk patients, or patients with chronic conditions. Those programs are designed to reduce hospitalizations and readmissions, which can go a long way to lowering Humana's expenses.

For example, healthcare costs for members enrolled in Humana's Chronic Care Program, or HCCP, are 40% lower than costs for those who haven't enrolled in HCCP. Results for Humana's Transitions program are similarly impressive. Transitions members are 50% less likely to be readmitted to the hospital after being discharged than those who haven't enrolled in the program.

Fool-worthy final thoughts
It's not all clear sailing for insurers. Humana's profit is being squeezed on one side by the approval of next generation, high-cost medicine, and on the other side by members demanding lower monthly premiums. That suggests that pressure on insurer margin isn't going to ease anytime soon.

However, the significant opportunity for membership growth suggests that, as long as margins remain similar to current levels, earnings should continue to trend higher. If so, investors willing to take the long view on Humana may find that they're rewarded with higher share prices.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There's a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns, you will need The Motley Fool's new free report on the dream team responsible for this game-changing blockbuster. CLICK HERE NOW.

Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers